BrainCool adds two sites to PRINCESS 2 cardiac arrest trial

PUBT · 2d ago
BrainCool adds two sites to PRINCESS 2 cardiac arrest trial
  • BrainCool plans interim results from its COTTIS 2 stroke trial in the first half of 2027; enrollment remains ongoing.
  • Positive interim findings could support expansion of the study beyond Germany.
  • The PRINCESS 2 cardiac arrest trial added sites in Oslo and Halle; interim analysis will follow enrollment of 400 patients.
  • Preparations with distributor ZOLL continue for a 2027 launch of BrainCool System in Taiwan; Japanese market authorization remains under review.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BrainCool AB published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.